SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma

被引：0
|
作者：
Zengbin Wang
Banglun Pan
Lili Su
Huahui Yu
Xiaoxuan Wu
Yuxin Yao
Xiaoxia Zhang
Jiacheng Qiu
Nanhong Tang
机构：
[1] Fujian Medical University,Department of Immunology, School of Basic Medical Sciences
[2] Fujian Medical University Union Hospital,Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery
[3] Cancer Center of Fujian Medical University,undefined
[4] Fujian Medical University Union Hospital,undefined
[5] Key Laboratory of Gastrointestinal Cancer (Fujian Medical University),undefined
[6] Ministry of Education,undefined
来源：
Cellular Oncology | 2024年 / 47卷
关键词：
SUMOylation inhibitors; Intestinal microbiota; Immune microenvironment; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：513 / 532
页数：19
相关论文
共 50 条
  • [41] Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma
    Yuan, Lingyan
    Bing, Zhitong
    Han, Jiani
    An, Xiaoli
    Liu, Xingkui
    Li, Rui
    Wang, Caiyun
    Sun, Xueqiang
    Yang, Lei
    Yang, Kehu
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 124
  • [42] Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma
    Meng, Lei
    Ma, Rulan
    Yan, Rong
    Yuan, Dawei
    Li, Yijun
    Shi, Lei
    Li, Kang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (03) : 1152 - 1163
  • [43] Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model
    Cao, Hongru
    Huang, Ping
    Qiu, Jiawei
    Gong, Xiaohui
    Cao, Hongfei
    HELIYON, 2024, 10 (03)
  • [44] Eribulin has anti-tumor activity in a preclinical model of merkel cell carcinoma
    Miyamoto, K.
    Yanagi, T.
    Maeda, T.
    Kitamura, S.
    Ujiie, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S41 - S41
  • [45] Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma
    Hung Huynh
    Richard Ong
    Khee Chee Soo
    Angiogenesis, 2012, 15 : 59 - 70
  • [46] Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma
    Huynh, Hung
    Ong, Richard
    Soo, Khee Chee
    ANGIOGENESIS, 2012, 15 (01) : 59 - 70
  • [47] Anti-tumor efficacy and safety of AEV01 in preclinical glioblastoma and hepatocellular carcinoma models
    Biswas, Indrani
    Precilla, Senthilathiban Daisy
    Kumar, Aravinda
    Sekhar, M. M.
    Medasani, Renu
    Anitha, T. S.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [48] Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma
    Zhang, Haohan
    Yao, Yi
    Wu, Jie
    Zhou, Jin
    Zhao, Chen
    He, Junju
    Xu, Bin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Anti-Tigit induces T cell mediated anti-tumor immune response and combines with immune checkpoint inhibitors to enhance strong and long term anti-tumor immunity
    Srivastava, Minu K.
    Yun, Rui
    Mayes, Erin
    Yu, Janice
    Jie, Hyun-Bae
    Axelrod, Fumiko
    Xie, Ming-Hong
    Monteon, Jorge
    Lam, Andrew
    Ji, May
    Liu, Yuwang
    Lewicki, John
    Hoey, Tim
    Gurney, Austin
    Park, Angie Inkyung
    CANCER RESEARCH, 2017, 77
  • [50] Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model
    Dung, Nguyen Tien
    Susukida, Takeshi
    Ucche, Sisca
    He, Ka
    Sasaki, So-ichiro
    Hayashi, Ryuji
    Hayakawa, Yoshihiro
    NUTRIENTS, 2023, 15 (16)
12345